HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Our company has 45 years track record in DNA production.
We are recognised for being able to provide DNA for both topical and injectable applications, with a very low level of impurities.
Features
Advantages
Moisture retention
Free radical scavenger
Anti-peroxidizing activities
Healing effect